BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35618983)

  • 1. Cognitive dysfunction following COVID-19 infection.
    Hadad R; Khoury J; Stanger C; Fisher T; Schneer S; Ben-Hayun R; Possin K; Valcour V; Aharon-Peretz J; Adir Y
    J Neurovirol; 2022 Jun; 28(3):430-437. PubMed ID: 35618983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Mini-Mental State Examination and Montreal Cognitive Assessment executive subtests in detecting post-stroke cognitive impairment.
    Fu C; Jin X; Chen B; Xue F; Niu H; Guo R; Chen Z; Zheng H; Wang L; Zhang Y
    Geriatr Gerontol Int; 2017 Dec; 17(12):2329-2335. PubMed ID: 28675607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?
    Lynch S; Ferrando SJ; Dornbush R; Shahar S; Smiley A; Klepacz L
    Gen Hosp Psychiatry; 2022; 78():80-86. PubMed ID: 35930974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cognitive functions in adult individuals with COVID-19.
    Akıncı B; Oğul ÖE; Hanoğlu L; Kulaç B; Ören D; Ulu O; Basançelebi B
    Neurol Sci; 2023 Mar; 44(3):793-802. PubMed ID: 36574178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19.
    Hosp JA; Dressing A; Blazhenets G; Bormann T; Rau A; Schwabenland M; Thurow J; Wagner D; Waller C; Niesen WD; Frings L; Urbach H; Prinz M; Weiller C; Schroeter N; Meyer PT
    Brain; 2021 May; 144(4):1263-1276. PubMed ID: 33822001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 severity is related to poor executive function in people with post-COVID conditions.
    Ariza M; Cano N; Segura B; Adan A; Bargalló N; Caldú X; Campabadal A; Jurado MA; Mataró M; Pueyo R; Sala-Llonch R; Barrué C; Bejar J; Cortés CU; ; Garolera M; Junqué C
    J Neurol; 2023 May; 270(5):2392-2408. PubMed ID: 36939932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of extent and pattern of neurocognitive functions in mild and moderate traumatic brain injury patients by using Montreal Cognitive Assessment (MoCA) score as a screening tool: An observational study from India.
    Panwar N; Purohit D; Deo Sinha V; Joshi M
    Asian J Psychiatr; 2019 Mar; 41():60-65. PubMed ID: 30396805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic
    Wood JL; Weintraub S; Coventry C; Xu J; Zhang H; Rogalski E; Mesulam MM; Gefen T
    J Int Neuropsychol Soc; 2020 Oct; 26(9):927-931. PubMed ID: 32423505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.
    Hagen E; Sømhovd M; Hesse M; Arnevik EA; Erga AH
    J Subst Abuse Treat; 2019 Feb; 97():21-27. PubMed ID: 30577896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and cognitive impairment: A cross-sectional clinic-based study.
    Siddig A; Abbasher Hussien Mohamed Ahmed K; Abdelrahman A; Abbasher A; Abbasher AA; Abbasher M; Hussien A
    Brain Behav; 2022 Mar; 12(3):e2538. PubMed ID: 35195949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).
    Aiello EN; Fiabane E; Manera MR; Radici A; Grossi F; Ottonello M; Pain D; Pistarini C
    Neurol Sci; 2022 Jan; 43(1):81-84. PubMed ID: 34668124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results.
    Pirker-Kees A; Platho-Elwischger K; Hafner S; Redlich K; Baumgartner C
    Dement Geriatr Cogn Disord; 2021; 50(1):68-73. PubMed ID: 33853062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.
    Koll TT; Sheese AN; Semin J; Ernst W; High R; Wildes TM; Fisher A; Murman DL
    J Geriatr Oncol; 2020 Mar; 11(2):297-303. PubMed ID: 31831362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis.
    Crivelli L; Palmer K; Calandri I; Guekht A; Beghi E; Carroll W; Frontera J; García-Azorín D; Westenberg E; Winkler AS; Mangialasche F; Allegri RF; Kivipelto M
    Alzheimers Dement; 2022 May; 18(5):1047-1066. PubMed ID: 35297561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
    Tiffin-Richards FE; Costa AS; Holschbach B; Frank RD; Vassiliadou A; Krüger T; Kuckuck K; Gross T; Eitner F; Floege J; Schulz JB; Reetz K
    PLoS One; 2014; 9(10):e106700. PubMed ID: 25347578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montreal Cognitive Assessment of cognitive dysfunction after basal ganglia stroke.
    Ye B; Wei D; Pan L
    Acta Neurol Belg; 2022 Aug; 122(4):881-884. PubMed ID: 35624396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cognitive, mental, and sleep patterns of post-acute COVID-19 patients and their correlation with thorax CT.
    Bolattürk ÖF; Soylu AC
    Acta Neurol Belg; 2023 Jun; 123(3):1089-1093. PubMed ID: 35752747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations for interpreting failure on individual subtests of the Montreal Cognitive Assessment.
    Moafmashhadi P; Koski L
    J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):19-28. PubMed ID: 23385364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19.
    Valdes E; Fuchs B; Morrison C; Charvet L; Lewis A; Thawani S; Balcer L; Galetta SL; Wisniewski T; Frontera JA
    J Neurol Sci; 2022 Jul; 438():120146. PubMed ID: 35031121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
    Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
    J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.